Eli Lilly said it could spin off or sell its animal health business, a segment that contributed 15% of the pharmaceutical company’s revenue last year but has been pressured in recent years by competition.
from WSJ.com: US Business http://ift.tt/2h3YCf9
via IFTTT
No comments:
Post a Comment